Literature DB >> 7013026

Kidney transplantation in patients 60 years and older.

N Wedel, H Brynger, I Blohmè.   

Abstract

Between 1967 and 1978 41 patients were transplanted at an age of 60 years or more. The patient survival was approximately 50% at two years. Most of the dead patients died with functioning grafts. Infections and cardiovascular complications dominated as causes of death. Main complications were cardiovascular diseases, infections, musculosceletal diseases and diabetes. During the last three years results have improved and we will continue to offer kidney transplantation to elderly patients in terminal renal failure.

Entities:  

Mesh:

Year:  1980        PMID: 7013026

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  5 in total

1.  Perspectives of Older Kidney Transplant Recipients on Kidney Transplantation.

Authors:  Jule Pinter; Camilla S Hanson; Jeremy R Chapman; Germaine Wong; Jonathan C Craig; Jane O Schell; Allison Tong
Journal:  Clin J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 8.237

Review 2.  Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?

Authors:  H U Meier-Kriesche; B Kaplan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Renal transplantation for patients 60 years of older. A single-institution experience.

Authors:  E Benedetti; A J Matas; N Hakim; C Fasola; K Gillingham; L McHugh; J S Najarian
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

5.  Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.

Authors:  Antonella D'Ambrosio; Luciana Giordani; Manuela Colucci; Nicola Vanacore; Francesca Quintieri
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.